{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:49:45Z","timestamp":1792633785392,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81528021"],"award-info":[{"award-number":["81528021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"publisher","award":["MYRG112 (Y1-L3)-ICMS13-ZY"],"award-info":[{"award-number":["MYRG112 (Y1-L3)-ICMS13-ZY"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.phrs.2017.08.017","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T04:17:05Z","timestamp":1504325825000},"page":"246-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"PB","title":["Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier"],"prefix":"10.1016","volume":"125","author":[{"given":"Ye","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongkai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Ming-Yuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.08.017_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7243\/2052-6946-1-3","article-title":"Central nervous system diseases and the role of the blood-brain barrier in their treatment","volume":"1","author":"Dom\u00ednguez","year":"2013","journal-title":"Neurosci. Discov."},{"key":"10.1016\/j.phrs.2017.08.017_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11481-007-9099-6","article-title":"Novel nanomaterials for clinical neuroscience","volume":"3","author":"Gilmore","year":"2008","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.fitote.2012.12.009","article-title":"Recent advances in herbal medicines treating parkinson's disease","volume":"84","author":"Li","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phrs.2017.08.017_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/957875","article-title":"Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of parkinson\u2019s disease","volume":"2013","author":"More","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.phrs.2017.08.017_bib0025","first-page":"195","article-title":"Quercetin exerts a neuroprotective effect through inhibition of the inos\/no system and pro-inflammation gene expression in pc12 cells and in zebrafish","volume":"27","author":"Zhang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2017.08.017_bib0030","article-title":"Pharmacokinetic study and optimal formulation of new anti-parkinson natural compound schisantherina","volume":"2015","author":"Sa","year":"2015","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.phrs.2017.08.017_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nbd.2009.07.033","article-title":"Assessment of the blood?brain barrier in cns drug discovery","volume":"37","author":"Jeffrey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2017.08.017_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"L\u00f6scher","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood\u2013brain barrier structure and function and the challenges for cns drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.phrs.2017.08.017_bib0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of peptide and protein drugs over the blood\u2013brain barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.phrs.2017.08.017_bib0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.drudis.2011.04.004","article-title":"Models for predicting blood\u2013brain barrier permeation","volume":"16","author":"Nielsen","year":"2011","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.phrs.2017.08.017_bib0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2017.08.017_bib0070","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","article-title":"Expression, up-regulation, and transport activity of the multidrug-resistance protein abcg2 at the mouse blood-brain barrier","volume":"64","author":"Cisternino","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.08.017_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2011-1828","article-title":"In vitro models of the blood-brain barrier","volume":"71","author":"Wilhelm","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.phrs.2017.08.017_bib0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1471-4159.2011.07434.x","article-title":"Blood\u2013brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons","volume":"119","author":"Lippmann","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2017.08.017_bib0085","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S1359-6446(03)02858-7","article-title":"New approaches to in vitro models of blood\u2013brain barrier drug transport","volume":"8","author":"Terasaki","year":"2003","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.phrs.2017.08.017_bib0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/138920008786485182","article-title":"Assays to predict drug permeation across the blood-brain barrier, and distribution to brain","volume":"9","author":"Abbott","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2017.08.017_bib0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ddtec.2004.11.014","article-title":"Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models","volume":"1","author":"Abbott","year":"2004","journal-title":"Drug Discov. Today: Technol"},{"key":"10.1016\/j.phrs.2017.08.017_bib0100","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1023\/A:1011942814300","article-title":"Effects of pluronic p85 unimers and micelles on drug permeability in polarized bbmec and caco-2 cells","volume":"15","author":"Batrakova","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2017.08.017_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-10-33","article-title":"Comparative study of four immortalized human brain capillary endothelial cell lines, hcmec\/d3, hbmec, ty10, and bb19, and optimization of culture conditions, for an in vitro blood\u2013brain barrier model for drug permeability studies","volume":"10","author":"Eigenmann","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.phrs.2017.08.017_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ar.b.20087","article-title":"Development of the blood-brain barrier: A historical point of view","volume":"289","author":"Ribatti","year":"2006","journal-title":"Anat. Rec. Part B: N. Anat."},{"key":"10.1016\/j.phrs.2017.08.017_bib0115","first-page":"10","article-title":"Modeling the blood-brain barrier using stem cell sources","author":"Lippmann","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.phrs.2017.08.017_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.107.130294","article-title":"Progress in brain penetration evaluation in drug discovery and development","volume":"325","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.08.017_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2017.08.017_bib0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood\u2013brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00441-008-0658-9","article-title":"Brain endothelial cells and the glio-vascular complex","volume":"335","author":"Wolburg","year":"2009","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.phrs.2017.08.017_bib0140","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1471-4159.2008.05720.x","article-title":"Abc transporters, cytochromes p450 and their main transcription factors: expression at the human blood\u2013brain barrier","volume":"107","author":"Dauchy","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2017.08.017_bib0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","article-title":"Drug and gene delivery to the brain: the vascular route","volume":"36","author":"Pardridge","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2017.08.017_bib0150","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"Abc transporters and the blood-brain barrier","volume":"10","author":"Begley","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2017.08.017_bib0155","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous lc\/ms\/ms method combined with novel in-silico peptide selection criteria","volume":"25","author":"Kamiie","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2017.08.017_bib0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd1606","article-title":"In vivo drug discovery in the zebrafish","volume":"4","author":"Zon","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2017.08.017_bib0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/138920009787522197","article-title":"Zebrafish: a complete animal model for in vivo drug discovery and development","volume":"10","author":"Chakraborty","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2017.08.017_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2008.05.130","article-title":"Zebrafish based assays for the assessment of cardiac, visual and gut function\u2014potential safety screens for early drug discovery","volume":"58","author":"Berghmans","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.phrs.2017.08.017_bib0175","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ntt.2004.06.014","article-title":"Sensitivity of zebrafish to environmental toxins implicated in parkinson's disease","volume":"26","author":"Bretaud","year":"2004","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0180","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.0000061912.88753.87","article-title":"Drugs that induce repolarization abnormalities cause bradycardia in zebrafish","volume":"107","author":"Milan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.08.017_bib0185","first-page":"32","article-title":"Can zebrafish be used as animal model to study alzheimer\u2019s disease","volume":"1","author":"Santana","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.phrs.2017.08.017_bib0190","doi-asserted-by":"crossref","first-page":"11386","DOI":"10.1158\/0008-5472.CAN-07-3126","article-title":"Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish","volume":"67","author":"Tran","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.08.017_bib0195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11910-011-0182-2","article-title":"Modeling neurodegeneration in zebrafish","volume":"11","author":"Xi","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.phrs.2017.08.017_bib0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1387\/ijdb.8735932","article-title":"Large scale genetics in a small vertebrate, the zebrafish","volume":"40","author":"Haffter","year":"1996","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0205","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/NDT.S2056","article-title":"Zebrafish: an in vivo model for the study of neurological diseases","volume":"4","author":"Best","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.phrs.2017.08.017_bib0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jep.2010.05.016","article-title":"Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro huvec model","volume":"131","author":"Alex","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.reprotox.2011.10.018","article-title":"Zebrafish developmental screening of the toxcast\u2122 phase i chemical library","volume":"33","author":"Padilla","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/17425250902882128","article-title":"The use of in vivo zebrafish assays in drug toxicity screening","volume":"5","author":"Eimon","year":"2009","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/adt.2010.0346","article-title":"The zebrafish: a powerful platform for in vivo, hts drug discovery","volume":"9","author":"Delvecchio","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0230","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/bies.10326","article-title":"Zebrafish: a new model on the pharmaceutical catwalk","volume":"25","author":"Langheinrich","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.phrs.2017.08.017_bib0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jep.2012.11.003","article-title":"Zebrafish: a nontraditional model of traditional medicine","volume":"145","author":"Littleton","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ntt.2006.04.003","article-title":"A zebrafish assay for identifying neuroprotectants in vivo","volume":"28","author":"Parng","year":"2006","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0245","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1039\/c3tb20528b","article-title":"In vivo nanotoxicity testing using the zebrafish embryo assay","volume":"1","author":"Rizzo","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.phrs.2017.08.017_bib0250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/dbio.2000.9995","article-title":"The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development","volume":"230","author":"Isogai","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0255","doi-asserted-by":"crossref","first-page":"e77548","DOI":"10.1371\/journal.pone.0077548","article-title":"Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish","volume":"8","author":"Fleming","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.08.017_bib0260","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/2070","article-title":"Impaired blood\u2013brain barrier function in angiotensinogen-deficient mice","volume":"4","author":"Kakinuma","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2017.08.017_bib0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-60761-938-3_18","article-title":"Zebrafish model of the blood-brain barrier: morphological and permeability studies","author":"Eliceiri","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0270","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0166-2236(00)02004-X","article-title":"Molecular physiology and pathophysiology of tight junctions in the blood\u2013brain barrier","volume":"24","author":"Huber","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2017.08.017_bib0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1083\/jcb.147.1.185","article-title":"Endothelial claudin claudin-5\/tmvcf constitutes tight junction strands in endothelial cells","volume":"147","author":"Morita","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-213X-10-76","article-title":"A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development","volume":"10","author":"Xie","year":"2010","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0285","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.brainresbull.2007.10.043","article-title":"Functional and developmental analysis of the blood\u2013brain barrier in zebrafish","volume":"75","author":"Jeong","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2017.08.017_bib0290","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.modgep.2007.05.006","article-title":"Identification, tissue distribution and developmental expression of tjp1\/zo-1, tjp2\/zo-2 and tjp3\/zo-3 in the zebrafish, danio rerio","volume":"7","author":"Kiener","year":"2007","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.phrs.2017.08.017_bib0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: atp-binding cassette gene family","volume":"2","author":"L\u00f6scher","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.phrs.2017.08.017_bib0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the atp binding cassette (abc) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2017.08.017_bib0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/157015909788848901","article-title":"Mechanisms of the penetration of blood-borne substances into the brain","volume":"7","author":"Ueno","year":"2009","journal-title":"Current Neuropharmacol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygeno.2006.03.001","article-title":"Evolution of the vertebrate abc gene family: analysis of gene birth and death","volume":"88","author":"Annilo","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.phrs.2017.08.017_bib0315","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0024-3205(92)90537-Y","article-title":"P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells","volume":"51","author":"Tsuji","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2017.08.017_bib0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/clpt.2012.168","article-title":"Zebrafish as a model to study drug transporters at the blood\u2013brain barrier","volume":"92","author":"Umans","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2017.08.017_bib0325","series-title":"Zebrafish: Methods for Assessing Drug Safety and Toxicity","first-page":"177","article-title":"Zebrafish A new in vivo model for identifying p-glycoprotein efflux modulators","author":"Park","year":"2012"},{"key":"10.1016\/j.phrs.2017.08.017_bib0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/biof.5520170111","article-title":"Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate","volume":"17","author":"V\u00e1radi","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.phrs.2017.08.017_bib0335","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroscience.2008.06.015","article-title":"Subcellular localization of transporters along the rat blood\u2013brain barrier and blood\u2013cerebral-spinal fluid barrier by in vivo biotinylation","volume":"155","author":"Roberts","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2017.08.017_bib0340","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s11033-010-0283-z","article-title":"Molecular analysis and heavy metal detoxification of abcc1\/mrp1 in zebrafish","volume":"38","author":"Long","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phrs.2017.08.017_bib0345","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0090-9556(24)15245-2","article-title":"Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro","volume":"27","author":"Gutmann","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2017.08.017_bib0350","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/jpet.104.076216","article-title":"P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice","volume":"312","author":"Park","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.08.017_bib0355","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/dmd.104.002964","article-title":"Molecular cloning, baculovirus expression, and tissue distribution of the zebrafish aldehyde dehydrogenase 2","volume":"33","author":"Lassen","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2017.08.017_bib0360","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cne.21057","article-title":"Distinct structure and activity of monoamine oxidase in the brain of zebrafish (danio rerio)","volume":"498","author":"Anichtchik","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0365","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/eesa.1999.1845","article-title":"Uptake, toxicity, and effects on detoxication enzymes of atrazine and trifluoroacetate in embryos of zebrafish","volume":"45","author":"Wiegand","year":"2000","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.phrs.2017.08.017_bib0370","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1111\/j.1742-4658.2005.04791.x","article-title":"Identification of a novel thyroid hormone-sulfating cytosolic sulfotransferase, sult1 st5, from zebrafish","volume":"272","author":"Yasuda","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2017.08.017_bib0375","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1039\/c1mb00001b","article-title":"Combined in vivo imaging and omics approaches reveal metabolism of icaritin and its glycosides in zebrafish larvae","volume":"7","author":"Li","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.phrs.2017.08.017_bib0380","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/138920011798357024","article-title":"Interplay of drug metabolizing cyp450 enzymes and abc transporters in the blood-brain barrier","volume":"12","author":"Decleves","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2017.08.017_bib0385","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.abb.2008.12.002","article-title":"Cytochrome p450 1d1: A novel cyp1a-related gene that is not transcriptionally activated by pcb126 or tcdd","volume":"482","author":"Goldstone","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2017.08.017_bib0390","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1440-1681.1997.tb02718.x","article-title":"Structure and function of uridine diphosphate glucuronosyltransferases","volume":"24","author":"Meech","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0395","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/abbi.1998.0842","article-title":"Identification of the uridine diphosphate glucuronosyltransferase isoform ugt1a6 in rat brain and in primary cultures of neurons and astrocytes","volume":"358","author":"Suleman","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2017.08.017_bib0400","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.toxlet.2012.07.014","article-title":"Effect of oxidative stress on udp-glucuronosyltransferases in rat astrocytes","volume":"213","author":"Gradinaru","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2017.08.017_bib0405","first-page":"9","author":"Ouzzine","year":"2015"},{"key":"10.1016\/j.phrs.2017.08.017_bib0410","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/epi.12318","article-title":"Expression and functional relevance of ugt1a4 in a cohort of human drug-resistant epileptic brains","volume":"54","author":"Ghosh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2017.08.017_bib0415","doi-asserted-by":"crossref","first-page":"e9144","DOI":"10.1371\/journal.pone.0009144","article-title":"Cloning and comparative analyses of the zebrafish ugt repertoire reveal its evolutionary diversity","volume":"5","author":"Huang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.08.017_bib0420","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.aquatox.2014.02.019","article-title":"Tissue-, sex-and development-specific transcription profiles of eight udp-glucuronosyltransferase genes in zebrafish (danio rerio) and their regulation by activator of aryl hydrocarbon receptor","volume":"150","author":"Christen","year":"2014","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0425","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/138920011798357051","article-title":"Blood-brain barrier p450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases","volume":"12","author":"Ghosh","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2017.08.017_bib0430","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jcbfm.2008.16","article-title":"Coordinated nuclear receptor regulation of the efflux transporter, mrp2, and the phase-ii metabolizing enzyme, gst\u03c0, at the blood\u2014brain barrier","volume":"28","author":"Bauer","year":"2008","journal-title":"J. Cereb. Blood Flow Metabol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0435","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.aquatox.2014.10.013","article-title":"Characterization of glutathione-s-transferases in zebrafish (danio rerio)","volume":"158","author":"Glisic","year":"2015","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0440","series-title":"Permeability Barrier: Methods and Protocols","first-page":"369","article-title":"Assessment of permeability in barrier type of endothelium in brain using tracers: evans blue, sodium fluorescein, and horseradish peroxidase","author":"Kaya","year":"2011"},{"key":"10.1016\/j.phrs.2017.08.017_bib0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10571-004-1374-y","article-title":"Dynamics of cns barriers: evolution, differentiation, and modulation","volume":"25","author":"Abbott","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0450","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2202-13-101","article-title":"In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish","volume":"13","author":"Watanabe","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.phrs.2017.08.017_bib0455","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1113\/jphysiol.2011.225896","article-title":"A method for detecting molecular transport within the cerebral ventricles of live zebrafish (danio rerio) larvae","volume":"590","author":"Turner","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2017.08.017_bib0460","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lfs.2005.12.034","article-title":"Long-term l-name treatment potentiates the blood\u2013brain barrier disruption during pentylenetetrazole-induced seizures in rats","volume":"79","author":"Kalayci","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2017.08.017_bib0465","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/cn400010t","article-title":"Identification of a novel indoline derivative for in vivo fluorescent imaging of blood-brain barrier disruption in animal models","volume":"4","author":"Nishimura","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2017.08.017_bib0470","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (xr9576): A p-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.phrs.2017.08.017_bib0475","series-title":"Zebrafish","article-title":"Zebrafish as a screening model for testing the permeability of blood\u2013brain barrier to small molecules","author":"Kim","year":"2017"},{"key":"10.1016\/j.phrs.2017.08.017_bib0480","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0306-3623(95)02112-4","article-title":"Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential","volume":"27","author":"Hoult","year":"1996","journal-title":"Gen. Pharmacol.: Vasc. Syst."},{"key":"10.1016\/j.phrs.2017.08.017_bib0485","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.6b01680","article-title":"Transport mechanism of coumarin 6 nanocrystals with two particle size in mdckii monolayer and larval zebrafish","author":"Miao","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2017.08.017_bib0490","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.colsurfb.2017.05.022","article-title":"Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers","volume":"156","author":"Li","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.phrs.2017.08.017_bib0495","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1021\/acsami.7b01171","article-title":"Small-sized mpeg-plga nanoparticles of schisantherin a with sustained release for enhanced brain uptake and anti-parkinsonian activity","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2017.08.017_bib0500","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (tfr) trafficking determines brain uptake of tfr antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2017.08.017_bib0505","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jvim.12596","article-title":"A review of paclitaxel and novel formulations including those suitable for use in dogs","volume":"29","author":"Khanna","year":"2015","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.phrs.2017.08.017_bib0510","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2017.08.017_bib0515","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2017.08.017_bib0520","first-page":"5","article-title":"Carbon quantum dots for zebrafish fluorescence imaging","author":"Kang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2017.08.017_bib0525","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.colsurfb.2016.05.007","article-title":"Crossing the blood\u2013brain\u2013barrier with transferrin conjugated carbon dots: a zebrafish model study","volume":"145","author":"Li","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.phrs.2017.08.017_bib0530","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jab.2016.01.004","article-title":"Development of biocompatible nanogel for sustained drug release by overcoming the blood brain barrier in zebrafish model","volume":"14","author":"Kalaiarasi","year":"2016","journal-title":"J. Appl. Biomed."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817304425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817304425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T13:45:00Z","timestamp":1750859100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817304425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":106,"alternative-id":["S1043661817304425"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.08.017","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}